1. Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial 
Edward Y. Sako, MD, PhD, Maria Mori Brooks, PhD, Regina M. Hardison, MS, Hartzel Schaff, MD, Robert L. Frye, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 148, Issue 4, Pages (October 2014)
DOI: /j.jtcvs
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
The percentage of patients who experienced death, myocardial infarction (MI), or stroke in the 30 days after the assigned coronary artery bypass grafting procedure in Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. The MIs were classified by the BARI 2D Electrocardiographic Core Laboratory, and the strokes were adjudicated by a centralized events classification committee. CABG, Coronary artery bypass grafting.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions